Oncology in Biological Technology
Navigation Links
Oncology in Biological Technology
...
"During the American Society of Clinical oncology Annual Meeting, we reported promising Phase 2 ... CRC at the 2009 American Society of Clinical oncology (ASCO) Annual Meeting. The results continue to ... capital and royalties for Poniard to develop an oncology business in the United States.
...
... Amgen will commercialize the drug for PMO and oncology in the United States (U.S.) and Canada and for all oncology indications in Europe and specified markets. ... and commercialize denosumab in Japan in PMO and oncology with the potential for additional indications. ...
... and tumor specific data to enhance the value of oncology drugs, has established a collaboration with ... following nearly a year of efforts to build our oncology drug pipeline we expect to in-license additional ... data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a ...
... the July 10 issue of the Journal of Clinical oncology . The retrospective study compared how well CTCs ... professor in the Department of Breast Medical oncology at The University of Texas M. D. Anderson ... physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly ...
... Care Advantage(TM) , its national oral oncology specialty pharmacy service, has exceeded the $15 ... assistance from charitable foundations. The US oncology pharmacy announced it had reached the $10 million ... the laborious process from community-based oncology practice staff so that they can spend more time ...
... online in the cancer journal, Annals of oncology , represent a significant advancement for the ... in both the American Society of Clinical oncology (ASCO) and the National Comprehensive Cancer ... study published in the Journal of Clinical oncology . To date, more than 8,000 physicians have ...
... specialist capabilities in in vitro, cell-based oncology assays which will now be available in a ... affiliate so O2h can now support its clients with oncology focused cell biology assays. Dan Cowell, ... custom cell biology research services within the oncology therapeutic area. Hypoxium's goal is to provide ...
... and Chief of Haematology and Medical oncology at The University of Texas Health Science ... 2008 and at the American Society of Clinical oncology (ASCO) in May 2009. Based on the final data from ... Clavis Pharma Clavis Pharma ASA is an oncology focused pharmaceutical company using ...
... presentation at the American Society of Clinical oncology (ASCO) Annual Meeting. Analyses indicated a ... during the 2009 American Society of Clinical oncology Annual Meeting (ASCO) today, May 30, 2009. The ... in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a ...
... partner by providing a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal. MedTrust Online will add Exiqon ... case studies available to MedTrust's growing oncology health care provider user base consisting of ...
... at the 45th American Society of Clinical oncology (ASCO) Annual Meeting in Orlando, Fla., from May ... L.P. or its research partner, Ortho Biotech oncology Research and Development, a unit of Johnson & ... Clinical Diagnostics, Raritan, NJ; Ortho Biotech oncology Research & Development, Raritan, NJ; ...
... Meeting of the American Society of Clinical oncology (ASCO), scheduled for May 29 through June 2 in ... study related to prostate cancer conducted by our oncology diagnostics team at Nichols Institute. While more ... (C) 2005-2009 American Society of Clinical oncology (ASCO). All rights reserved worldwide. ...
... at the 2009 American Society of Clinical oncology (ASCO) annual meeting. "Nexavar has a proven ... Joaquim Bellmunt, M.D., Chief of the Solid Tumor oncology Section, Medical oncology Service, University Hospital del Mar-IMIM, ...
... Whisenhunt brings more than 18 years of radiation oncology industry experience to the Company. Prior to ... position of Vice President and General Manager of oncology Business at Picker Medical Systems and spent four years as the Director of oncology Marketing for GE Medical Systems. Stephen is a ...
... and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions ... UK Ltd. (CBUK), to expand its personalized oncology business. Guy Malchi has been appointed General ... of our business, particularly in our personalized oncology service. Significantly, much of the increased ...
Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
... as Vice President and General Manager of the oncology Business Unit. In this role, Phillips will have responsibility for managing all aspects of the U.S. oncology business including Sales, Marketing and Medical ... will support the dynamic growth of the Cephalon oncology business and allow us to continue to bring ...Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
... company and a leading developer of oncology compounds directed to cancer stem cell targets, ... current decision making with respect to oncology drug development. With this in mind, Dr. ... stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. ...... Amgen will commercialize the drug for PMO and oncology in the United States (U.S.) and Canada and for all oncology indications in Europe and specified markets. ... and commercialize denosumab in Japan in PMO and oncology with the potential for additional indications. ...
Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer
... Inc., the developer of non-invasive molecular oncology diagnostics to aid in early cancer detection and ... licensing and production of exosome non-invasive oncology assay." Mr. Zdechlik, an in-vitro ... molecular diagnostic tests with applications in oncology and metabolic disease. The company's core ...... and tumor specific data to enhance the value of oncology drugs, has established a collaboration with ... following nearly a year of efforts to build our oncology drug pipeline we expect to in-license additional ... data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a ...
... the July 10 issue of the Journal of Clinical oncology . The retrospective study compared how well CTCs ... professor in the Department of Breast Medical oncology at The University of Texas M. D. Anderson ... physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly ...
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
... & Johnson and will work with Ortho Biotech oncology Research & Development, a unit of Centocor ... we have strengthened our position in the global oncology market and our efforts to provide a meaningful ... Global Therapeutic Head, Oncology, Ortho Biotech oncology Research & Development. "Abiraterone acetate ...... Care Advantage(TM) , its national oral oncology specialty pharmacy service, has exceeded the $15 ... assistance from charitable foundations. The US oncology pharmacy announced it had reached the $10 million ... the laborious process from community-based oncology practice staff so that they can spend more time ...
Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
... a biopharmaceutical company focused on innovative oncology therapies, today announced the appointment of ... our strategy of building a commercial stage oncology business." "I look forward to working with ... development and commercialization of innovative oncology products to impact the lives of people with ...... online in the cancer journal, Annals of oncology , represent a significant advancement for the ... in both the American Society of Clinical oncology (ASCO) and the National Comprehensive Cancer ... study published in the Journal of Clinical oncology . To date, more than 8,000 physicians have ...
... specialist capabilities in in vitro, cell-based oncology assays which will now be available in a ... affiliate so O2h can now support its clients with oncology focused cell biology assays. Dan Cowell, ... custom cell biology research services within the oncology therapeutic area. Hypoxium's goal is to provide ...
... and Chief of Haematology and Medical oncology at The University of Texas Health Science ... 2008 and at the American Society of Clinical oncology (ASCO) in May 2009. Based on the final data from ... Clavis Pharma Clavis Pharma ASA is an oncology focused pharmaceutical company using ...
Oncothyreon appoints Scott Peterson as Vice President of Research and Development
... the advancement of the Company's pipeline of oncology product candidates into late phase clinical ... he has served as Director and Department Head, oncology Research, since 2007. In that capacity he has led ... most recently as a Principal Scientist in oncology Drug Discovery. At ICOS he was involved in both ...Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy
... professionals the rare opportunity to view the oncology space and its current and future operational ... the day and improve their knowledge of real-world oncology issues at the NCCN Academy for Excellence & ... & Leadership in Oncology(TM) series of oncology certificate programs designed by the National ...Americas on the Waterway Supports US Oncology Foundation
... US oncology employees enjoy after work social and pledge ... work social and pledge drive to support the US oncology Foundation . (Photo: ... of the event was to raise awareness about the US oncology Foundation and garner pledges for the ...Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors
... Results Presented at American Society of Clinical oncology (ASCO) Meeting Show Fleximer(R) Conjugated Drug ... Meeting of the American Society of Clinical oncology (ASCO) in Orlando. XMT-1001 is a broad-spectrum ... University of Maryland, Baltimore , MD; New York oncology Hematology, Albany, NY; TGen Clinical Research ...... presentation at the American Society of Clinical oncology (ASCO) Annual Meeting. Analyses indicated a ... during the 2009 American Society of Clinical oncology Annual Meeting (ASCO) today, May 30, 2009. The ... in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a ...
... partner by providing a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal. MedTrust Online will add Exiqon ... case studies available to MedTrust's growing oncology health care provider user base consisting of ...
... at the 45th American Society of Clinical oncology (ASCO) Annual Meeting in Orlando, Fla., from May ... L.P. or its research partner, Ortho Biotech oncology Research and Development, a unit of Johnson & ... Clinical Diagnostics, Raritan, NJ; Ortho Biotech oncology Research & Development, Raritan, NJ; ...
... Meeting of the American Society of Clinical oncology (ASCO), scheduled for May 29 through June 2 in ... study related to prostate cancer conducted by our oncology diagnostics team at Nichols Institute. While more ... (C) 2005-2009 American Society of Clinical oncology (ASCO). All rights reserved worldwide. ...
OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
... during the 2009 American Society of Clinical oncology Annual Meeting (ASCO) on Saturday, May 30, 2009. ... presentation at the American Society of Clinical oncology (ASCO) Annual Meeting, as well as discuss the ... in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a ...SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
... Spector served as Chief Executive Officer of AAI oncology & General Manager of AAI Pharma France which is an oncology focused multinational Contract Research ... responsible for the strategic direction of the oncology operations, business development and clinical ...Agendia Opens CLIA-Registered U.S. Genomics Laboratory
... a practicing oncologist and director of several oncology programs. Dr. Bender has served as Medical ... Program at Quest Diagnostics, Director of Medical oncology and Hematology at Kaiser Permanente Medical ... Dr. Bender serves as an expert reviewer in oncology for the Medical Board of California, co-Editor of ...Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
... Prostate Cancer Treatment Strengthens Presence in oncology NEW BRUNSWICK, N.J., and LOS ANGELES, May 21 ... multiple myeloma, will work with Ortho Biotech oncology Research & Development, a unit of Centocor ... toward a leadership position in the global oncology market," said William N. Hait, M.D., Ph.D., ...US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
... Working with Deloitte Consulting , US oncology developed PatientRM as a cost effective ... businesses: AccessMED(TM) , Innovent oncology , OncologyRx Care Advantage(TM) and oncology Reimbursement Solutions , and has the capability ...... at the 2009 American Society of Clinical oncology (ASCO) annual meeting. "Nexavar has a proven ... Joaquim Bellmunt, M.D., Chief of the Solid Tumor oncology Section, Medical oncology Service, University Hospital del Mar-IMIM, ...
Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
... a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, ... provide a corporate overview at the Leerink Swann oncology Roundtable Conference on Wednesday, May 20, at ... development and commercialization of innovative oncology products to impact the lives of people with ...Lilly Set to Unveil More Than 50 Studies at ASCO 2009
... Meeting of the American Society of Clinical oncology (ASCO) in Orlando, Fla. from May 29 to June 2, ... Lilly vice president, cancer research and global oncology platform leader. "We are focused on delivering ... to meeting the needs of patients across a broad oncology spectrum." Studies of note for ALIMTA ...... Whisenhunt brings more than 18 years of radiation oncology industry experience to the Company. Prior to ... position of Vice President and General Manager of oncology Business at Picker Medical Systems and spent four years as the Director of oncology Marketing for GE Medical Systems. Stephen is a ...
Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
... the Outside In" Program to Launch at the Annual oncology Nursing Society Congress THOUSAND OAKS, ... AMGN ) and ONS Edge , a subsidiary of the oncology Nursing Society (ONS), today announced that they ... Outside In . The initiative is aimed at educating oncology nurses about the skin-related side effects ...US Oncology to Report 2009 First Quarter Operating Results
... About US oncology US Oncology, Inc., headquartered in the ... patient access to advanced cancer care. US oncology supports one of the nation's foremost cancer ... medicine and shared best practices. US oncology uses its expertise to support every aspect of the ...SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance
... Alliance provides global oncology clinical development solutions in North America, ... Flemington, NJ, USA, a service provider in oncology drug development with a business concentration in ... This alliance will enable SIRO to expand its oncology clinical development and patient recruitment ...Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team
... and shepherding the late-stage development of new oncology therapeutics, will be invaluable as Proteolix ... manufacture and marketing for Immunex oncology and neurology products. Mr. Parker ... and regulatory strategy, particularly for novel oncology products. In his new role, Dr. Kraus will be ...US Oncology Launches New Web Site
... is part of a new branding effort to position US oncology as a diversified company touching every aspect of ... physicians resources to find top-quality oncology care in a convenient, easy-to-navigate Web site. ... For the first time, the entire US oncology story is told via the left-hand navigation ...US Oncology Encourages Your Right to Decide
... Dr. Russell Hoverman , physician with Texas oncology ( www.texasoncology.com ), an affiliated practice of US oncology . "With advance directives like a living will or ... section at www.usoncology.com . About US oncology US Oncology, Inc., headquartered in the ...US Oncology Clinical Development Attends 'Partnerships With CROs'
... HOUSTON, April 13 /PRNewswire/ -- US oncology Clinical Development (USOCD), a full service ... the clinical trial management process. US oncology Clinical Development has exclusively managed oncology clinical trials for the last 10 years. Between a ...... and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions ... UK Ltd. (CBUK), to expand its personalized oncology business. Guy Malchi has been appointed General ... of our business, particularly in our personalized oncology service. Significantly, much of the increased ...
Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
... focus on the many accomplishments for Pharmatech oncology in cancer clinical trials utilizing the ... of patients being offered trials. "Pharmatech oncology is honored to be selected from a large number of ... highest quality of clinical research. Pharmatech oncology provides services of a Site Management ...US Oncology Provides Full Service Management of Clinical Trials
... HOUSTON, April 2 /PRNewswire/ -- US oncology , the nation's foremost cancer treatment and research network, has established US oncology Clinical Development (USOCD), a full service ... USOCD formalizes many of the services that US oncology Research has provided since its inception in ...Other ContentshealthyhealthyhealthyhealthyhealthyhealthyhealthyhealthyhealthyhealthyheterophilepointerhiphiphiphiphiphipprocedureprocedureprocedureprocedureprocedureprocedureprocedureprocedureprocedureprocedurepathologypathologypathologypathologypathologypathologypathologyassistantassistantassistantassistantassistantassistantOther TagsCemCemCemCemCemCemCemStyletTMETMETMETMETMEAlignAlignOther Tagsdreams 2opposed 2opposed 3opposed 4opposed 5opposed 6opposed 7opposed 8opposed 9dropping 2dropping 3sorry 2estimates 2estimates 3estimates 4estimates 5estimates 6estimates 7road 2road 3put 2put 3put 4put 5put 6put 7put 8put 9put 10biomass 2metals 2
(Date:12/4/2009)...halogram (EEG) is widely used by physicians and sc...eurological disorders. However, it has remained la...ive an exact view of what is happening inside the ...Biological Cybernetics in Tbingen, Germany, have n...ated within the brain to that measured with EEG. T...
(Date:12/4/2009)...ery is challenging accepted thinking about amyloid...seases such as Alzheimer,s and Parkinson,s and ma..., It was believed that amyloid fibrils - rope-lik...s fibres - are inert, but that there may be toxic ...ls and cause disease. , But in a paper publishe...
(Date:12/3/2009)... learn new information and adapt to changes in our...memories, appears to lie in the minute junctions w...tudy by NYU Langone Medicine Center researchers. T...nal Nature . , The scientists, led by Wen-Biao...euroscience at NYU School of Medicine, discovered ...
Breaking Biology News(10 mins):How to read brain activity? 2New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2Circle Medical Devices Texcel Medical Merge to Form CIRTEC Medical Systems 5558 1Circle Medical Devices Texcel Medical Merge to Form CIRTEC Medical Systems 5558 2Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 1Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 2Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 3Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 4Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5556 5Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 1Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 2(Date:12/4/2009)...la., Dec. 4 NeoGenomic...ay that Steven C. Jones has been appointed Executi...oza has joined the company as Chief Financial Offi... all internal financial affairs of the Company. I... strategic initiatives on behalf of NeoGenomics as...
(Date:12/4/2009)...Mo., Dec. 4 Farmers Insurance Miss... Fire Marshal Randy Cole, and Brad Ballard, the CE...sponsored by Farmers called FireFacts , will ...ri Capitol December 9. ,, (Logo: http://www... "The call for fire safety comes following a tragi...
(Date:12/4/2009)...indings by UT Southwestern researchers suggest tha...s might also help slow the destruction of insulin-...h insulin-dependent (type 1) diabetes. , In typ... cells in the pancreas called beta cells, which pr...ess. , Researchers at UT Southwestern and 14 oth...
(Date:12/4/2009)...conveys true personality, study finds , ,...file on an online social network, such as Facebook...oes, reports a new study, which finds that people ...ized identities. , "I was surprised by the fin...eople are using their profiles to promote an enhan...
(Date:12/4/2009)...S, LLC, a leader in Pharmacy Inventory Management ...USA IDN Health Systems and hospitals valued at $22...mber to grow to over $30 million by the end of 200...December 4, 2009 -- PHACTS, LLC, a leader in Pharm... agreements in 2009 with USA IDN Health Systems an...
Breaking Medicine News(10 mins):Health News:NeoGenomics Announces Executive Appointments 2Health News:Missouri Safety Day at the Capitol 2Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Online Identities Likely to Match Reality 2Health News:PHACTS Receives $22.4 Million in New Business Commitments 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |